Great West Life Assurance CO Beam Therapeutics Inc. Transaction History

Great West Life Assurance CO

$69.9 Billion
Q3 2025

A detailed history of Great West Life Assurance CO transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 29,762 shares of BEAM stock, worth $655,359. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,762

Previous 28,160 5.69%

Holding current value

$655,359

Previous $480,000 48.13%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 17, 2025	BUY	$16.01 - $25.1 $25,648 - $40,210	1,602 Added 5.69%	29,762 $711,000
Q2 2025 Aug 14, 2025	BUY	$14.54 - $20.24 $280,113 - $389,923	19,265 Added 216.58%	28,160 $480,000
Q1 2025 May 15, 2025	BUY	$19.53 - $34.09 $7,069 - $12,340	362 Added 4.24%	8,895 $174,000
Q4 2024 Feb 13, 2025	SELL	$21.55 - $30.35 $13,813 - $19,454	-641 Reduced 6.99%	8,533 $212,000
Q3 2024 Nov 13, 2024	BUY	$22.57 - $33.14 $7,764 - $11,400	344 Added 3.9%	9,174 $225,000

Q2 2024 Aug 12, 2024	BUY	$21.22 - $32.66 $21,326 - $32,823	1,005 Added 12.84%	8,830 $207,000
Q1 2024 May 13, 2024	BUY	$23.46 - $45.07 $9,290 - $17,847	396 Added 5.33%	7,825 $259,000
Q4 2023 Feb 13, 2024	BUY	$17.69 - $30.76 $18,379 - $31,959	1,039 Added 16.26%	7,429 $200,000
Q3 2023 Nov 14, 2023	BUY	$23.01 - $32.46 $69,030 - $97,380	3,000 Added 88.5%	6,390 $154,000
Q2 2023 Aug 10, 2023	BUY	$29.32 - $35.99 $5,893 - $7,233	201 Added 6.3%	3,390 $109,000
Q1 2023 May 12, 2023	SELL	$30.15 - $48.79 $7,386 - $11,953	-245 Reduced 7.13%	3,189 $98,000
Q4 2022 Feb 10, 2023	BUY	$36.73 - $51.6 $17,152 - $24,097	467 Added 15.74%	3,434 $136,000
Q3 2022 Nov 01, 2022	BUY	$39.79 - $70.31 $118,056 - $208,609	2,967 New	2,967 $142,000
Q2 2022 Aug 09, 2022	BUY	$29.86 - $62.36 $31,800 - $66,413	1,065 Added 58.26%	2,893 $112,000
Q1 2022 May 12, 2022	BUY	$53.73 - $82.16 $3,546 - $5,422	66 Added 3.75%	1,828 $112,000
Q4 2021 Feb 14, 2022	BUY	$68.02 - $99.06 $4,285 - $6,240	63 Added 3.71%	1,762 $140,000
Q2 2021 Aug 11, 2021	BUY	$64.12 - $128.71 $42,190 - $84,691	658 Added 63.21%	1,699 $218,000
Q1 2021 May 17, 2021	SELL	$71.28 - $120.75 $26,017 - $44,073	-365 Reduced 25.96%	1,041 $83,000
Q2 2020 Aug 17, 2020	BUY	$15.26 - $28.66 $21,455 - $40,295	1,406 New	1,406 $39,000

Others Institutions Holding BEAM

# of Institutions

249

Shares Held

95M

Call Options Held

888K

Put Options Held

549K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.55B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Beam Therapeutics Inc. Transaction History